ARKG Increases Over 36% as Biotech’s Rebound Enters Second Month

Biotech’s rally hasn’t let up, as shares of the ARK Genomic Revolution ETF (ARKG) have increased nearly 37% over the past month. A surge in biotech share prices that began in mid-June is lasting longer than skeptics expected. Shares of ARKG were trading at $27.20 on June 13 and have risen to...